🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Financials Sector SEC Filings — May 18, 2026

The May 18, 2026 batch of 50 S&P 500 Financials filings reveals a sector bifurcated between large-cap stability and small/mid-cap distress. The most significant event is the $2.5B all-cash acquisition of LiveRamp by Publicis Groupe at a 30% premium, signaling strong M&A appetite for data assets. However, this is overshadowed by severe distress signals: Bitcoin Depot has entered bankruptcy proceedings, and Gossamer Bio is executing a coercive debt-for-equity swap requiring 98% participation. Period-over-period trends show a mixed picture: LiveRamp's 9% YoY revenue growth and 107% net retention contrast sharply with iSpecimen's 85% revenue collapse and OLB Group's 29% decline. Insider activity is notably absent across most filings, but management actions—such as Wyndham's CEO disclosing a cancer diagnosis while reaffirming guidance—provide nuanced signals. Capital allocation trends are defensive: Coeur Mining has aggressively repurchased $69.7M of stock, while Presidio Property Trust is cutting debt and CEO pay. The overarching theme is capital preservation and strategic repositioning, with M&A and restructuring dominating the narrative over organic growth.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 18, 2026

The 50 filings for the S&P 500 Consumer Staples stream reveal a sector in transition, with significant capital allocation shifts, governance battles, and a few high-growth outliers. While the majority of filings are procedural (annual meeting results, proxy statements), several high-materiality events stand out. **Altria Group** faces a high-risk director departure, while **CoStar Group** is undertaking a major governance and capital allocation overhaul in response to activist pressure, including a $1.5B buyback. **CleanCore Solutions** presents a significant red flag with a material restatement and internal control weakness, contrasting with **Koil Energy Solutions** which reported record revenue and a return to profitability. **Claritev Corp** disclosed a DOJ antitrust probe, adding regulatory risk. The most actionable themes are the push for shareholder-friendly capital returns (CoStar, CCEP) and the severe financial reporting issues at CleanCore, which serve as a cautionary tale for micro-cap investors. Overall, the sector shows a mix of stable, cash-generating businesses returning capital and smaller players facing existential challenges.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 18, 2026

The 50 filings from the S&P 500 Industrials stream reveal a sector bifurcated between robust growth in niche areas (e.g., shipping, medical devices) and significant financial distress in others (e.g., Bitcoin Depot's Bitcoin Depot's bankruptcy, Banzai's dilution). Period-over-period data shows strong revenue growth at Bally's (+28.3% YoY) and Genco Shipping (swinging to a $9.3M profit from an $11.9M loss), but also highlights margin compression and cash burn at several firms. Insider activity is limited, but the heavy insider-related financing at Yale Transaction Finders and the departure of FedEx's CAO are notable. Capital allocation trends are mixed, with Bally's refinancing debt and Genco raising dividends, while others like Tofutti Brands and ABVC Biopharma face severe cash constraints. The most critical developments include Bitcoin Depot's bankruptcy, Bally's major project advancements, and the FedEx Freight spin-off, which together signal a 'survival of the fittest' dynamic in the industrials space.

24 high priority 26 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 18, 2026

The three filings for the S&P 500 Energy stream on May 18, 2026, represent a very quiet session with no direct energy sector activity. The primary developments are procedural steps in XOMA Royalty Corp's merger with Ligand Pharmaceuticals, involving a holding company reorganization that does not alter economic terms. Chesapeake Wealth Management's 13F filing provides a snapshot of a diversified portfolio with no energy-specific concentration. No period-over-period comparisons, insider trading, forward-looking guidance, or capital allocation changes were present in any of the filings, limiting actionable insights. The absence of energy sector filings and the lack of enriched data trends (e.g., revenue growth, margin changes) indicate a lull in sector activity. Investors should monitor for upcoming earnings calls and regulatory decisions from major energy companies to identify future catalysts.

1 high priority 2 medium 3 total filings
· daily

US Material Events SEC 8-K Filings — May 18, 2026

The May 18, 2026, filing cycle reveals a market bifurcated between aggressive capital deployment and acute financial distress. The dominant themes are a wave of equity and debt financing (Akamai, Babcock & Wilcox, Ideal Power, Old Republic) aimed at funding growth and strategic initiatives, contrasted with a high-profile bankruptcy at Bitcoin Depot and a major acquisition of LiveRamp by Publicis. Leadership transitions are widespread, with several companies (Flagstar, NextEra Energy, T. Rowe Price) executing planned successions, while others (Wyndham, CVS Health) face unexpected changes. A notable trend is the use of convertible notes and equity facilities, which provide capital but introduce dilution risks. The healthcare sector shows significant positive activity, with ImmunityBio and Context Therapeutics advancing key pipeline assets. Overall, the data suggests a market where well-capitalized firms are aggressively pursuing growth, while others are restructuring or facing existential challenges.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 18, 2026

The May 18, 2026 batch of 50 filings from the Dow 30 universe reveals a market bifurcated between aggressive capital deployment and operational strain. A dominant theme is the use of equity-linked financing and M&A to fund growth, with notable examples including LiveRamp's $2.5B all-cash acquisition by Publicis Groupe at a 30% premium, Bally's $4.0B Bronx development and $1.1B refinancing, and Soluna's $53M wind farm acquisition. However, this expansion is occurring against a backdrop of widening losses and cash burn for many companies, as seen in Soluna's net loss doubling to $17.9M and ABVC Biopharma's 79% loss increase with zero revenue. Insider activity is sparse but notable, with director resignations at Innoviva and significant shareholder dissent on pay at Nicolet Bankshares (32.7% against). Capital allocation is mixed: while some firms like Virgin Galactic are using stock to pay down debt, others like Babcock & Wilcox are raising $200M via dilutive offerings. The forward-looking calendar is rich with catalysts, including the July 6, 2026 Clough fund meetings and the May 19, 2026 NBT Bancorp annual meeting, but also carries risks from pending regulatory approvals (CFIUS on LiveRamp) and ongoing Nasdaq compliance issues (Faraday Future). Overall, the data suggests a market where strategic bets are being placed, but the financial health of the underlying companies requires close scrutiny of cash flow and margin trends.

29 high priority 21 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 18, 2026

Today's filings reveal a bifurcated market: robust M&A activity (LiveRamp acquisition at 30% premium, Artivion's $175M Endospan buy) contrasts with severe distress signals (Bitcoin Depot bankruptcy, Gossamer Bio restructuring). Revenue trends are mixed—LiveRamp (+9% YoY) and Coeur Mining's buyback execution show strength, while iSpecimen (-85% revenue decline) and OLB Group (-28.6%) highlight micro-cap fragility. Insider activity is sparse but notable: Wyndham CEO's health disclosure introduces leadership uncertainty. Capital allocation patterns diverge sharply—CoreCivic's buyback program contrasts with Perma-Fix's dilutive offering. Sector themes include consolidation in building products (QXO/TopBuild), biotech restructuring (Gossamer Bio, Context Therapeutics), and crypto-exposed portfolios (SkyBridge's 97% Bitcoin concentration). The catalyst calendar features LiveRamp shareholder vote, Gossamer Bio exchange offer deadline, and Context Therapeutics' Phase 1 trial initiation.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 18, 2026

The 50 filings from the S&P 500 Consumer Discretionary sector reveal a sector in transition, marked by aggressive capital restructuring, significant insider activity, and a clear bifurcation between companies investing for growth and those facing operational headwinds. A dominant theme is the use of high-cost debt and equity-linked financing, with Wayfair issuing $400M in 7.125% notes and Faraday Future securing $70M in convertible notes, signaling elevated borrowing costs and potential dilution. Insider trading patterns are a key signal, with the CEO of Fermi Inc. ousted for cause and a proxy battle underway, while O'Reilly Automotive's board approved a $2M stock option for its executive chairman, indicating confidence. Period-over-period data shows mixed performance: Fatpipe Inc. grew revenue 17.9% YoY but saw operating cash flow turn negative, while Tofutti Brands saw sales decline 2.1% and losses widen. Capital allocation is a key differentiator, with InfuSystem announcing a $20M buyback and O'Reilly maintaining shareholder returns, contrasting with the dilutive financing at Flux Power and Profusa. The most critical development is the $1.5B MiRus investment by Boston Scientific, a bold bet on the TAVR market, while the ongoing proxy fight at Fermi Inc. and the short-term forbearance at FiscalNote highlight governance and liquidity risks. Overall, the sector shows a 'haves and have-nots' dynamic, where strong balance sheets are being used for strategic M&A and buybacks, while weaker players are forced into costly financing and face shareholder activism.

23 high priority 27 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 18, 2026

The 45 filings for the S&P 500 Healthcare sector reveal a sector in transition, marked by aggressive M&A (Neurocrine's $2.9B Soleno deal, Boston Scientific's $B MiRus investment) and significant capital allocation shifts (Bally's refinancing, CoreWeave's $B AI infrastructure debt). Period-over-period data shows a stark divergence: medical device and specialty pharma companies are posting strong growth (Catheter Precision +202% YoY, Bally's +28%), while diagnostics and smaller biotechs face severe revenue declines (iSpecimen -85% YoY). Insider activity is mixed, with notable director departures at Medtronic and CVS, but also new appointments at Flagstar Bank and Cellectar. Forward-looking data highlights a busy catalyst calendar with upcoming FDA decisions, shareholder votes, and clinical trial readouts. Capital allocation trends show a preference for debt-funded M&A and share buybacks, with several companies (Webster, CCEP) facing governance scrutiny over deal terms and executive compensation. Overall, the sector is experiencing a 'barbell' effect where large-cap players are consolidating and investing in high-growth areas (AI, gene therapy, TAVR), while smaller players struggle with cash burn and operational challenges.

15 high priority 30 medium 45 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 18, 2026

This batch of 10 proxy filings reveals a mixed landscape for the 2026 annual meeting season, with the season, with the most actionable intelligence concentrated in T1 Energy's aggressive growth plans and Flag Ship Acquisition's existential deadline. T1 Energy stands out with strong first-year operational results—2.79 GW of solar modules manufactured and $755.3 million in net sales—but the proposal to double authorized shares from 500 million to 1 billion creates significant dilution risk for existing holders. The three Clough funds (GLQ, GLO, GLV, GLO) are purely procedural, offering no financial data or compensation insights, while Braze and SmartKem provide governance and committee activity details without quantitative performance metrics. Flag Ship Acquisition Corp presents a binary event: if the extension proposal fails, the SPAC will liquidate by June 20, 2026, rendering public rights worthless. Snowflake's Creations shows a board reduction from six to five members as Shirley Romig steps down, signaling potential governance streamlining. Overall, the lack of enriched period-over-period data in most filings limits trend analysis, but the few actionable filings that do contain operational data point to capital-intensive growth strategies and governance scrutiny as key themes for the June-July 2026 meeting window.

10 high priority 10 total filings
· daily

Global High-Priority Regulatory Events — May 18, 2026

The May 18, 2026 filing stream reveals a market bifurcated between aggressive strategic consolidation and acute financial distress. The most dominant theme is a wave of transformative M&A, led by NextEra Energy's $38B+ bid for Dominion Energy and Publicis Groupe's $2.5B acquisition of LiveRamp acquisition signal a high-conviction bet on scale in-sector consolidation and data infrastructure, respectively. However, this bullish activity is sharply contrasted by severe distress signals: Bitcoin Depot has entered bankruptcy, MTNL has disclosed a massive ₹9,339 Cr default, and several micro-cap biote-stage biotechs (ABVC, iSpecimen) are burning cash with no revenue. Period-over-period data shows a stark divergence, with LiveRamp growing revenue 9% YoY and achieving record cash flow, while OLB Group and iSpecimen saw revenues collapse 28.6% and 85.2% YoY, respectively. Insider activity ispersed across these extremes, we see tactical capital deployment via buybacks (CMS Info Systems) and insider-driven moves (TVS Motor's strategic bank stake), alongside a flurry of regulatory and insolvency proceedings in India, indicating a market that is aggressively pricing in both future growth and imminent failure.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 18, 2026

The 27 filings reveal a stark bifurcation in the US micro-cap landscape: revenue growth is concentrated in a few outliers (CBAK Energy +99%, Hyperscale Data + Bally's Corp + Catheter Precision), while the majority of filers show revenue declines, zero revenue, or zero revenue with zero revenue. Period-over-period data shows aggregate revenue for the 27 filers fell ~15% YoY, with 14 of 27 reporting lower or zero revenue. Margin compression is severe—CBAK Energy's gross profit collapsed 78% despite revenue doubling, and NanoVibronix swung to a gross loss. Insider activity is absent in most filings, but capital allocation signals distress: 8 companies have zero cash, 5 are funding operations solely via related-party loans, and dilution is rampant (NanoVibronix shares outstanding surged 236% in one quarter). Forward-looking data is sparse, but scheduled events (earnings calls) for Bally's Corp and Hyperscale Data offer near-term catalysts. The most actionable themes are the 'cash-zero' cohort (6 companies with zero cash) and the 'revenue growth vs. margin destruction' trade-off in CBAK Energy and Hyperscale Data.

27 high priority 27 total filings
· daily

US SEC Trading Suspension Halt Orders — May 18, 2026

Two regulatory filings on May 18, 2026 highlight contrasting listing statuses: Palatin Technologies voluntarily delists from NYSE American to transfer to Nasdaq Capital Market, maintaining its symbol PTN, while Synergy CHC Corp. faces a Nasdaq deficiency notice for failing to maintain the $1.00 bid price, with a 180-day cure period until November 11, 2026. Palatin's move is neutral, reflecting a strategic exchange transfer without financial impact, whereas Synergy's situation is negative, signaling potential delisting risk. No period-over-period comparisons, insider transactions, or forward-looking guidance were provided in either filing, limiting trend analysis. The key takeaway is the divergence in exchange health: one company proactively upgrades, the other struggles to meet listing standards. Investors should monitor Synergy's compliance efforts, including a possible reverse stock split, and Palatin's Nasdaq debut for liquidity changes.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 18, 2026

The May 18, 2026, filing batch reveals a bifurcated corporate landscape: while several companies are executing strategic growth moves (e.g., CoreWeave's $3.1B oversubscribed AI infrastructure financing, LiveRamp's acquisition at a 30% premium), a significant cohort is exhibiting acute financial distress. The most critical signal is Bitcoin Depot's bankruptcy filing (Item 1.03), representing a total equity wipeout for shareholders. This is compounded by a wave of dilutive equity financings (Ideal Power, Babcock & Wilcox, Faraday Future) and covenant-laden credit amendments (Inotiv, Zevia) that signal liquidity stress. A notable pattern is the surge in capital markets activity, with $4.8B+ in new debt and equity issuance across just 10 filings, indicating companies are aggressively pre-funding or restructuring ahead of potential market turbulence. Insider trading data is sparse, but the absence of insider buying during these dilutive events is a bearish signal. The overarching theme is a 'flight to quality' where well-capitalized firms (CoreWeave, NextEra) access favorable terms, while distressed names (Bitcoin Depot, Inotiv) face punitive financing and existential risk.

50 high priority 50 total filings
· daily

US Executive Officer Management Changes SEC — May 18, 2026

The May 18, 2026, filing batch reveals a broad wave of planned leadership transitions across US equities, with 44 filings covering CEO, CFO, director, and key officer changes. A dominant theme is orderly succession planning, with 15+ filings showing internal promotions or planned retirements (e.g., NextEra Energy, Builders FirstSource, Eagle Bancorp Montana), signaling strong governance and reduced disruption risk. However, notable health-related disclosures (Wyndham CEO cancer diagnosis) and director resignations (Innoviva, AiXin Life) introduce uncertainty. Shareholder dissent is a recurring pattern: 6 companies (O'Reilly Automotive, Macy's, Marriott Vacations, Ultragenyx, Celcuity, ON Semiconductor) saw >10% against votes on director elections or equity plans, indicating governance friction. Capital allocation signals are mixed—T. Rowe Price reported $1.83T in assets (retirement-heavy), while Flagstar Bank extended CEO tenure amid return to profitability. No aggregate revenue or margin trends are available as filings lack financial statements, but forward-looking data points to key catalysts: FedEx Freight separation, Kyverna CAR-T approval path, and Super Micro consulting transition. Insider activity is limited but notable: Lesaka Technologies granted 1M options to Executive Chairman options at $5.00, and Fennec Pharmaceuticals issued inducement grants at $9.75. The overall risk profile is moderate, with 6 high-risk flags (Powerdyne, Altria, CVS, Aspen Aerogels, Celcuity, Macy's) and 12 positive sentiment signals, suggesting a cautiously bullish for well-governed firms.

44 high priority 44 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — May 18, 2026

The sole filing in today's bankruptcy intelligence stream is a comprehensive 8-K from Bitcoin Depot Inc., signaling a critical bankruptcy or receivership event (Item 1.03) combined with triggered financial obligations and executive departures. This filing represents a total equity value destruction event for shareholders, with the company—a Bitcoin ATM operator—facing likely Chapter 11 proceedings or similar restructuring. The enriched data reveals no period-over-period comparisons, insider activity, or forward-looking guidance, as the filing is a binary event disclosure rather than a periodic report. The bearish sentiment and critical risk level are fully justified, as the multiple 8-K items (1.03, 2.04, 5.02, 7.01, 9.01) indicate a comprehensive and severe financial collapse. Creditors face uncertain recovery rates, and the crypto-adjacent sector adds regulatory complexity. This is a singular, high-severity event with no portfolio-level trends to aggregate, but it serves as a stark reminder of the risks in the Bitcoin ATM and broader crypto infrastructure space.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 18, 2026

The 44 filings reveal a wave of board and C-suite changes across sectors, with notable insider departures at CVS, Hilton, and Aspen Aerogels (details missing) and planned successions at NextEra Energy, FedEx, and Builders FirstSource. Key period-over-period trends include strong shareholder support for say-on-pay at NACCO (99.7%) and Mastech (92.2%), but dissent at Macy's (78.6%) and Marriott Vacations (68.9% for equity plan). Insider activity is mixed: CEO Geoff Ballotti's health disclosure at Wyndham is a concern, while T. Rowe Price's leadership appointments signal strategic confidence. Capital allocation is stable, with no major buyback or dividend changes. The most critical development is the planned tax-free spin-off of FedEx Freight, which could unlock value. Sector themes include routine board refreshment, shareholder pushback on compensation plans, and a focus on AI and technology infrastructure appointments.

44 high priority 44 total filings
· daily

US Merger & Acquisition SEC Filings — May 18, 2026

The May 18, 2026, M&A landscape is dominated by a surge in SPAC activity, with four new IPOs (Berto, Patriot, GSR V, and the upsized Quantum Leap) collectively raising over $834 million, signaling robust appetite for blank-check vehicles despite a mixed track record. The most material event is Neurocrine Biosciences' $2.9B acquisition of Soleno Therapeutics, a high-conviction deal that closed with 88.9% shareholder tenders, adding a newly approved rare disease drug to its portfolio. However, this is contrasted by a high-risk, dilutive transaction at Quince Therapeutics, where existing shareholders are diluted to just 6.9% ownership post-merger, and a failed deal at Starry Sea Acquisition Corp., highlighting the binary nature of SPAC outcomes. A notable period-over-period trend is the shift toward operational maturity, with several SPACs (Iron Horse, Spring Valley) progressing toward definitive business combinations, while others (Quantum Leap) face going-concern warnings. Insider activity is limited but telling, with the Quince deal featuring significant PIPE investor participation ($187M) that signals external conviction despite massive dilution. The overall market implication is a bifurcated environment: capital is flowing freely into new SPACs, but execution risk remains high, and investors must discriminate between value-creating acquisitions and value-destructive structures.

16 high priority 16 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 18, 2026

The overnight filing cycle from May 17-18, 2026 reveals a bifurcated landscape: significant M&A activity with premiums (LiveRamp at 30% premium, Artivion $175M acquisition) contrasts with severe financial distress in micro-caps (Bitcoin Depot bankruptcy, iSpecimen 85% revenue decline). Period comparisons show mixed revenue trends—LiveRamp grew 9% YoY while OLB Group fell 28.6% and iSpecimen collapsed 85.2%. Margin compression was evident at LiveRamp (1ppt decline) and Presidio Property Trust (swung to net loss). Equity offerings dominated capital allocation (Perma-Fix, Flux Power, LanzaTech, Estrella), while Coeur Mining executed aggressive buybacks ($69.7M). Forward-looking catalysts include FDA decisions (Outlook Therapeutics May 2026), clinical trial starts (Context Therapeutics Q3 2026), and shareholder votes (CCEP AGM May 28, Gossamer Bio restructuring). Insider trading activity was absent from enriched data, but management changes at Wyndham (CEO health disclosure) and lululemon (CEO transition) add governance angles.

22 high priority 28 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — May 16, 2026

The single contract analyzed carries a total obligation of $544,658,997, awarded entirely to the civilian Department of State with zero defense-related activity. BL HARBERT INTERNATIONAL LLC received a definitive fixed-price contract with economic price adjustment for NEC Kinshasa construction under NAICS 236220, spanning from the 2022-09-28 award through 2029-02-19. The dominant theme is large-scale diplomatic infrastructure construction executed under full and open competition without set-asides. The highest-conviction signal is the neutral 5/10 rating on a $544.7 million award that has generated zero outlays to date. Key watch items include the $27.6 million flowing through 68 subawards and potential impacts from the economic price adjustment mechanism on a contract extending into 2029.

1 total filings